Ethical fashion brand to the royals Beulah is planning to raise £250k through equity crowdfunding platform SyndicateRoom. The company, which received a £250k investment from Mustard Seed earlier this month, will use the proceeds to continue to scale the development of its product range and to supports its growth plan.
Founded in 2010, Beulah London is a luxury fashion brand dedicated to raising awareness of the plight of women trapped by human slavery. With prices ranging from £30 to £765, the brand offers a comprehensive product line, spanning tops, skirts, dresses, jackets, trousers, scarves and bags.
Its social commitment and stylish outfits have captured attention from notable personalities, including the Duchess of Cambridge, Donna Air, Darcey Bussell, Jessica Alba and Princess Eugenie.
“Thinking of ways in which we could generate the funds needed to grow our business wasn’t an easy process,” said Beulah London co-founder Natasha Rufus Isaacs. “Initially we were sceptical about fundraising through a crowdfunding platform because of the luxury brand image… We are all very excited to be able to open our business up to the crowd as we move on to the next stage of our journey.”
Beulah generated £1.4m in revenue over the past four years, with £340k generated in 2015. After repositioning the business model to increase focus on India-based production, the company expects to achieve greater scalability of its products and create more opportunities for victims of human trafficking.
Alongside the fashion brand, Beulah's founders Lady Natasha Rufus Isaacs and Lavinia Brennan run Beulah Trust, a charitable foundation aimed at supporting initiatives that create sustainable livelihoods for victims of trafficking.
Read more here.
1 min read
Bankless Times - SyndicateRoom completes successful raise for medical company
4 min read
Wealth Advisor - Beulah London set to raise half a million through Cambridge crowdfunding platform SyndicateRoom
4 min read
BioSpace - SyndicateRoom Brings Crowd To Over Six Million Fundraise For Cancer Treatment Company
2 min read